Kerecis Completes Successful Immunology Study
May 03, 2013 03:05 ET | Kerecis
DENVER, CO--(Marketwired - May 3, 2013) - Symposium on Advanced Wound Care -- Kerecis today announced that its recent clinical trial found no allergenic reactions to its fish-skin-composed MariGen...
DUX Dental Logo
German Study Finds Bacteria on Seventy Percent of Dental Bib Holders
March 19, 2012 13:43 ET | DUX Dental
OXNARD, Calif., March 19, 2012 (GLOBE NEWSWIRE) -- This week, researchers at the University of Witten/Herdecke in North Rhine-Westphalia, Germany released a clinical study indicating that the...
Breast Cancer Study With Hemispherx Biopharma's Ampligen(R) Commences
August 22, 2011 10:00 ET | Hemispherx Biopharma, Inc.
PHILADELPHIA, Aug. 22, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE AMEX:HEB) announced that investigators from the Tumor Vaccine Group (TVG) at the University of Washington in Seattle, WA,...
Keryx Logo Side Icon.jpg
Keryx Announces Positive Interim Results From Phase 2 Clinical Study For KRX-101 -- Sulodexide Gelcaps -- For the Treatment of Diabetic Nephropathy
May 05, 2005 16:28 ET | Keryx Biopharmaceuticals, Inc.
Keryx to host conference call with Dr. Lewis tomorrow, Friday, May 6th at 8 am EDT NEW YORK, May 5, 2005 (PRIMEZONE) -- Keryx Biopharmaceuticals, Inc....